Brazil’s healthcare sector is undergoing an important period of regulatory and institutional transformation. On the public policy front, the recent approval of the National Strategy for the Health Economic-Industrial Complex (CEIS) and the new Clinical Research Law mark an important step toward providing greater institutional continuity and legal certainty for the sector. These developments also reinforce the role of Productive Development Partnerships (PDPs), following a new round of partnerships launched two years ago amid questions about their long-term continuity.
At the same time, important questions remain regarding implementation, the regulatory framework that will support these new initiatives, and the role of innovation and international cooperation in strengthening Brazil’s healthcare ecosystem.
Taken together, these developments create an important opportunity to discuss not only where the sector stands today but also what to expect in the coming months as key regulations are further developed, new policy decisions are announced, and Brazil approaches the 2026 presidential elections.
While the political environment naturally brings a degree of uncertainty, many of the recent initiatives and discussions point toward longer-term state policies rather than short-term government priorities. This creates a timely opportunity for a discussion focused on policy continuity, the evolving investment landscape, and opportunities for Brazil-U.S. cooperation.
Join the Brazil Program on Thursday, September 17, from 10:00 AM–11:00 AM ET for an online discussion on the latest regulatory and policy developments shaping Brazil’s healthcare sector and what to watch in the months ahead. The conversation will examine CEIS and PDPs, the new Clinical Research Law, current regulatory and implementation challenges, Brazil’s role in regional health production and innovation, and opportunities for investment and healthcare cooperation.
The event will be held in English.
